Q:
What are the different technologies available to deliver noninvasive positive pressure ventilation (NIPPV)? A: Dr Soll: The studies that assessed nasal ventilation used commonly available technologies. For instance, infants in most of the studies looking at NIPPV used technologies such as the Infant Star Ventilator. Synchronization was attempted using the same techniques that we use to synchronize infants on intermittent positive pressure ventilation (IPPV). The interfaces used were either nasopharyngeal or short binasal prongs. In fact, I believe, two of the three studies, which used nasopharyngeal prongs, showed that this approach might be a more stable interface for NIPPV administration compared to using short prongs. A: Dr Ramanathan: The most common interface used in the US is nasopharyngeal prongs. In the US, you don't have other ventilators that could deliver synchronized NIPPV. However, the European market has other ventilators that can be used to administer synchronized NIPPV. Still the most common one used is the Infant Star Ventilator. Q: There have been some studies of continuous positive ventilation (CPAP) in the baboon model showing benefits in terms of histological changes of BPD with the use of CPAP. Do these studies shed light on the benefits of NIPPV? A: Dr Soll: In terms of animal models, I am not aware of any specific work that has compared the lungs of animals treated with IPPV versus CPAP. Dr Ramanathan do you have any comments on animal models? A: Dr Ramanathan: The most common reason for failure of nasal CPAP is repeated episodes of apnea and bradycardia. I don't think baboons get apnea of prematurity; therefore, I am not sure how we can relate these data to humans. Also, there are no papers to my knowledge using NIPPV in the baboon model. Another issue with the baboon model is that they terminate the study by 14 days, although the more recent baboon models may go beyond that. The problem that has been seen in former baboon models is that the animals became septic and began to die after 14 days. Regarding the studies in premature baboons, nasal continuous positive airway pressure (NCPAP) has been shown to minimize lung injury at the histological level. Q: Is delivering positive pressure through a tube into the airway potentially detrimental to lung tissue? A: Dr Soll: The information that I reviewed showed short-term results in improvements with NIPPV. However, using positive pressures may not help or may be harmful. Further trials with longer durations are necessary to understand fully the effects of NIPPV.
